SCHEMBL10407464

SCHEMBL10407464

Cc1nc2nc(C(=O)O)cc([S])n2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 3/20 0.37
TP53 P04637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
POLB P06746 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HIF1A Q16665 1/20 0.37
GPR35 Q9HC97 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KMO O15229 1/20 0.34
HPGD P15428 1/20 0.33
AURKA O14965 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20065121 0.83 KMT2A (0.43) MEN1KMT2AKDM4ENPSR1LMNA
SCHEMBL9143356 0.83 LMNA (0.36) MEN1KMT2AKDM4ENPSR1LMNA
SCHEMBL10407378 0.81 KDM4E (0.38) MEN1KMT2AKDM4ELMNATP53
SCHEMBL9822245 0.80 MEN1 (0.34) MEN1KMT2AALOX15TSHRHIF1A
SCHEMBL10407399 0.80 MEN1 (0.38) MEN1KMT2AKDM4ENPSR1LMNA
SCHEMBL9822191 0.80 TSHR (0.34) MEN1KMT2AKDM4EALDH1A1ALOX15
SCHEMBL10407102 0.78 ALOX15 (0.33) MEN1KMT2AKDM4EALOX15TSHR
SCHEMBL10407780 0.78 ALDH1A1 (0.41) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9822230 0.78 HCAR2 (0.39) MEN1KMT2AKDM4ELMNATP53
SCHEMBL9822026 0.77 RECQL (0.36) KDM4EALDH1A1ALOX15TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4966900-A FOR MICROBISM THERAPY, BACTERIAL INFECTIONS SANKEI PHARMACEUTICAL COMPANY LTD. (JP) 1990-10-30 US disclosed
EP-0254495-A2 Beta-Lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1988-01-27 EP disclosed